Gambling on Biotechs—and Pfizer
Readers weigh in on Pfizer’s prospects, the record of activist funds, Linde and hydrogen, an options strategy for ASML Holding, the case for cash, and buying Tesla stock
This article was originally published by Marketwatch.com. Read the original article here.
